| 2025-12-16 |
详情>>
股本变动：
变动后总股本13500.48万股
|
| 2025-12-16 |
详情>>
业绩披露：
2025年年报每股收益-0.19加拿大元,归母净利润-2475.9万加拿大元,同比去年增长45.51%
|
| 2025-12-16 |
财报披露：
美东时间 2025-12-16 盘前发布财报
|
| 2025-08-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.10加拿大元,归母净利润1320.50万加拿大元,同比去年增长133.01%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年中报每股收益0.16加拿大元,归母净利润1949.90万加拿大元,同比去年增长145.53%
|
| 2025-03-03 |
股东大会：
将于2025-03-24召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company for its fiscal year ended September 30, 2024, and the report of the auditor thereon;
2.To elect directors of the Company for the ensuing year;
3.To appoint PKF O’Connor Davies LLP as the auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration of the auditor;
4.To consider, and if deemed advisable, approve a special resolution, the full text of which is set forth in Appendix “A” to this Circular, authorizing an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.”, when determined by the board of directors of the Company; all as more fully described in the accompanying management information circular (the “Circular”);
5.To consider other business that may properly come before the Meeting or any adjournment thereof.
|
| 2025-03-03 |
股东大会：
将于2025-03-24召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company for its fiscal year ended September 30, 2024, and the report of the auditor thereon;
2.To elect directors of the Company for the ensuing year;
3.To appoint PKF O’Connor Davies LLP as the auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration of the auditor;
4.To consider, and if deemed advisable, approve a special resolution, the full text of which is set forth in Appendix “A” to this Circular, authorizing an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.”, when determined by the board of directors of the Company; all as more fully described in the accompanying management information circular (the “Circular”);
5.To consider other business that may properly come before the Meeting or any adjournment thereof.
|
| 2025-02-11 |
详情>>
业绩披露：
2025年一季报每股收益-0.2加拿大元,归母净利润-2295.7万加拿大元,同比去年增长-45.76%
|
| 2024-12-06 |
复牌提示：
2024-12-06 09:10:07 停牌，复牌日期 2024-12-06 09:50:00
|
| 2024-08-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.39加拿大元,归母净利润-4000.7万加拿大元,同比去年增长81.44%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年中报每股收益-0.5加拿大元,归母净利润-4282.5万加拿大元,同比去年增长-1883.56%
|
| 2024-02-13 |
详情>>
业绩披露：
2024年一季报每股收益-0.19加拿大元,归母净利润-1575万加拿大元,同比去年增长-395.55%
|
| 2023-12-27 |
股东大会：
将于2024-01-18召开股东大会
会议内容 ▼▲
- 1.Election of Directors
Peter Amirault, Beena Goldenberg, Dexter John, Geoffrey Machum, Sherry Porter, Stephen A. Smith, Marni Wieshofer, Simon Ashton, Karina Gehring
2.Appointment of Auditor.Appointment of KPMG LLP as Auditor of the Organigram Holdings Inc. for the ensuing year and authorizing the Directors to fix their remuneration.
3.BT DE Investments Inc. Investment.To consider, and, if deemed advisable, approve an ordinary resolution, the full text of which is set forth in Appendix “A” to the Circular, authorizing the issuance by the Company of up to 183,679,525 Common Shares to BT DE Investments Inc. in connection with its investment of approximately C$124 million in the Company.
4.Articles of Amendment.To consider, and, if deemed advisable, approve a special resolution, the full text of which is set forth in Appendix “B” to the Circular, authorizing an amendment to the articles of the Company to create a new class of Class A preferred shares to be issued to BT DE Investments Inc. in connection with its investment in the Company.
|
| 2023-07-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.69加拿大元,归母净利润-2.16亿加拿大元,同比去年增长-2549.1%
|
| 2023-07-07 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2023-01-27 |
股东大会：
将于2023-02-28召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company for its fiscal year ended August 31, 2022, and the report of the auditor thereon;
2.To elect directors of the Company for the ensuing year;
3.To re-appoint KPMG LLP as the auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration of the auditor;
4.To re-approve the 2020 Equity Incentive Plan (as defined herein) previously approved by the shareholders on February 25, 2020;
5.To consider, and, if deemed advisable, approve the articles of amendment of the Company to delete the preferred shares from the authorized share capital of the Company;
6.To consider, and, if deemed advisable, approve the articles of amendment of the Company to delete the preferred shares from the authorized share capital of the Company;
7.To consider, and, if deemed advisable, approve the articles of amendment of the Company to effect a consolidation of the issued and outstanding common shares of the Company on the basis of a ratio to be determined by the board of directors of the Company, in its sole discretion, within a range of 1 post-consolidation common share for every 1.5 to 4 outstanding pre-consolidation common shares of the Company;
8.To consider other business that may properly come before the Meeting or any adjournment thereof.
|
| 2022-02-02 |
股东大会：
将于2022-02-23召开股东大会
会议内容 ▼▲
- 1.to receive and consider the audited consolidated financial statements of the Company for its fiscal year ended August 31, 2021, and the report of the former auditor thereon;
2.to elect directors of the Company for the ensuing year;
3.to appoint the successor auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration of the auditor;
4.to consider other business that may properly come before the Meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-02-01 |
股东大会：
将于2021-02-23召开股东大会
会议内容 ▼▲
- 1.to receive and consider the audited consolidated financial statements of the Company for its fiscal year ended August 31, 2020, and the report of the former auditor thereon;
2.to elect directors of the Company for the ensuing year;
3.to appoint the successor auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration of the auditor; 4.to consider other business that may properly come before the Meeting or any adjournment thereof.
|
| 2020-02-03 |
股东大会：
将于2020-02-25召开股东大会
会议内容 ▼▲
- 1.to receive and consider the audited consolidated financial statements of the Company for its fiscal year ended August 31, 2019, and the report of the auditor thereon;
2.to elect directors of the Company for the ensuing year;
3.to appoint the auditor of the Company for the ensuing year and to authorize the directors of the Company to fix the remuneration of the auditor;
4.to approve the articles of amendment of the Company;
5.to confirm the Amended and Restated By-Law No. 1 of the Company;
6.to approve a new omnibus equity incentive plan for the Company;
7.to act upon such other matters, including amendments to the foregoing, as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|